Lumida
/HUMA
⌘K
Humacyte Inc

Humacyte Inc

HUMA
$0.66USD+0.77%+0.01 today

MARKET CAP

179.2M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
Sell NowMedium

HUMA remains in a clear Stage 4 decline with sequential lower highs and lower lows. The medium-term bias is bearish, reinforced by a Bearish Pivot Point and Downtrend stage. Short-term price is extended below declining 9/21 EMAs, signaling momentum-driven selling readiness and supporting a Sell Now posture. Key risks include potential oversold bounces and near-term support clusters that could slow the decline.

  • Q1 2026 revenue $0.5M (+400% YoY) with CIMVEST unit sales of 29
  • FDA‐approved CIMVEST adoption accelerated by commercial team rebuild
  • Q1 2026 net loss $17.6M amid rising operating costs
Full analysis →